Sandostatin LAR and Tildrakizumab-asmn
Determining the interaction of Sandostatin LAR and Tildrakizumab-asmn and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sandostatin LAR-Tildrakizumab-asmn Subcutaneous
- Sandostatin LAR-Tilia Fe
- Sandostatin LAR-Tiludronate
- Sandostatin LAR-Timentin
- Sandostatin LAR-Timentin Add-Vantage
- Sandostatin LAR-Timentin Injection
- Tildrakizumab-asmn-Sandostatin LAR Depot
- Tildrakizumab-asmn-Sandostatin LAR Depot injection
- Tildrakizumab-asmn-Sani-Supp
- Tildrakizumab-asmn-Sani-Supp rectal
- Tildrakizumab-asmn-Sansert
- Tildrakizumab-asmn-Santyl